[Federal Register Volume 79, Number 139 (Monday, July 21, 2014)]
[Notices]
[Pages 42330-42331]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-17057]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee.

    Time and Date: 2:00 p.m.-4:30 p.m. EDT, August 13, 2014.
    Place: Teleconference.
    Status: This meeting is open to the public, limited only by the 
availability of telephone ports and webinar.
    Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW7936898&p=5994905&t=c. USA 
Telephone Dial-in number: 1-800-369-1780. Participant passcode: 
5994905 or URL: https://www.mymeetings.com/nc/join/.
    Conference number: PW7936898.
    Audience passcode: 5994905.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate use of immunizing agents. In addition, under 
42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contra-indications applicable 
to the vaccines. Further, under provisions of the Affordable Care 
Act, at section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been adopted by the Director 
of the Centers for Disease Control and Prevention must be covered by 
applicable health plans.
    Matters for Discussion: The agenda will include discussions on: 
Use of 13-valent pneumococcal conjugate vaccine and 23-valent 
pneumococcal polysaccharide vaccine in adults 65 years of age and 
older. A recommendation vote is scheduled. Time will be available 
for public comment.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie B. Thomas, 
National Center for Immunization and Respiratory Diseases, CDC, 1600 
Clifton Road, NE., MS-A27, Atlanta, Georgia 30333, telephone 404/
639-8836; Email [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and

[[Page 42331]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-17057 Filed 7-18-14; 8:45 am]
BILLING CODE 4160-18-P